TRANSCATHETER ATRIAL SEPTAL-DEFECT CLOSURE WITH THE DAS(TM) ANGEL-WINGS TRANSCATHETER ASD OCCLUSION DEVICE - THE CINCINNATI-ROCHESTER EXPERIENCE

Authors
MENDELSOHN AM BANERJEE A SCHWARTZ DC DAS GS
Citation
Am. Mendelsohn et al., TRANSCATHETER ATRIAL SEPTAL-DEFECT CLOSURE WITH THE DAS(TM) ANGEL-WINGS TRANSCATHETER ASD OCCLUSION DEVICE - THE CINCINNATI-ROCHESTER EXPERIENCE, Journal of interventional cardiology, 11(5), 1998, pp. 495-500
Citations number
3
Categorie Soggetti
Cardiac & Cardiovascular System
Journal title
Journal of interventional cardiology → ACNP
ISSN journal
08964327
Volume
11
Issue
5
Year of publication
1998
Part
1
Pages
495 - 500
Database
ISI
SICI code
0896-4327(1998)11:5<495:TASCWT>2.0.ZU;2-8
Abstract
The Angel Wings Das device, a recently developed transcatheter atrial septal defect occluder; represents a new approach to therapy of this c ongenital cardiac lesion. Overall, successful defect occlusion occurs in > 90% of patients following device implantation. We describe the ma jor design and technical issues pertinent to this device and review bo th international and personal local FDA Phase I trial results and comp lications. Future trial plans and device modifications are discussed.